Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
NEJM 2023: 10.1056/NEJMoa2301972 Phase 2 dose-response (1, 4, 8, 12 mg arms, 48 wk, non-diabetic obesity)
For these people, injections can be life-changing because they make blood sugar control easier, support weight loss, and protect the heart and kidneys, helping people feel healthier, more energised, and back in control of their lives
Retatrutide (LY3437943) is a synthetic research peptide developed by Eli Lilly
Friedman HS et al
Our services include: Initial in-clinic or telehealth assessment to confirm your suitability for intravenous nutrient therapy, arranging any required pathology testing, and the development of an intravenous nutrient therapy plan Delivery of intravenous therapy either in the clinic, or in the comfort of your own home Popular treatment options include simple IV rehydration, Vitamin C boosters, Glutathione supplementation and the Myers cocktail
A 2025 pilot study infused up to 20 mg of BPC157 intravenously in 2 healthy adults and reported no adverse effects and no abnormal changes in heart, liver, kidney, thyroid, or bloodglucose markers
